Rauschert Christian, Seitz Nicki-Nils, Olderbak Sally, Pogarell Oliver, Dreischulte Tobias, Kraus Ludwig
Department of Epidemiology and Diagnostics, IFT Institut für Therapieforschung, Munich, Germany.
Department of Psychology, University of Arizona, Tucson, AZ, United States.
Front Psychiatry. 2022 Apr 25;13:864389. doi: 10.3389/fpsyt.2022.864389. eCollection 2022.
Abuse of non-opioid analgesics (NOA) is associated with serious health consequences. However, due to inconsistent definitions of NOA abuse, prevalence estimates for the German population are unclear.
This study aimed to estimate the 12-month prevalence of NOA abuse among self-medicated users of these drugs in the general German population and to identify risk factors.
Data are from the 2015 Epidemiological Survey of Substance Abuse, a nationally representative sample with 9,204 individuals aged 18-64 years. Classification of NOA abuse was based on self-reported information according to the definition of the ICD-10-GM diagnosis F55.2 abuse of non-dependence producing substances. Multiple logistic regression was performed to examine associations between NOA abuse and sociodemographic, behavioral, and health-related variables.
The weighted 12-month prevalence of NOA abuse was 14.6% (95%-CI [13.2- 16.0]) among self-medicated users of these drugs. Extrapolation of the proportion of individuals abusing NOA to the German population aged 18 to 64 is 3,243,396 individuals or 6.4% (95%-CI [5.7- 7.1]). Inexplicable physical pain, being underweight, depression, hazardous alcohol use, daily smoking, illegal drug use, and frequent use of NOA (one or more times per week and daily use) were associated with an increased probability of NOA abuse. The use of cannabis was associated with a lower probability of NOA abuse.
Abuse of NOA is highly prevalent in the German population. Against the background of increasing self-medication of NOA, healthcare providers need to be aware of potential risk factors of abuse to better identify and prevent this problem.
滥用非阿片类镇痛药(NOA)会导致严重的健康后果。然而,由于对NOA滥用的定义不一致,德国人群中其滥用率的估计并不明确。
本研究旨在估计德国普通人群中自行用药的NOA使用者的12个月NOA滥用率,并确定风险因素。
数据来自2015年药物滥用流行病学调查,这是一个具有全国代表性的样本,包含9204名18 - 64岁的个体。NOA滥用的分类基于根据ICD - 10 - GM诊断F55.2非依赖性产生物质滥用的定义所报告的自我信息。进行多因素逻辑回归以检验NOA滥用与社会人口统计学、行为学和健康相关变量之间的关联。
在这些药物的自行用药使用者中,加权12个月NOA滥用率为14.6%(95%置信区间[13.2 - 16.0])。将滥用NOA的个体比例推算至德国18至64岁人群,为3243396人,即6.4%(95%置信区间[5.7 - 7.1])。不明原因的身体疼痛、体重过轻、抑郁、危险饮酒、每日吸烟、非法药物使用以及频繁使用NOA(每周一次或多次以及每日使用)与NOA滥用概率增加相关。使用大麻与NOA滥用概率降低相关。
NOA滥用在德国人群中非常普遍。在NOA自我用药增加的背景下,医疗保健提供者需要意识到潜在的滥用风险因素,以便更好地识别和预防这一问题。